STATUTORY RULES
1972 No.
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1972.*
WHEREAS it is provided by sub-section (4.) of section 101 of the National Health Act 1953-1972 that a drug or medicinal preparation that was not a pharmaceutical benefit under the National Health Act 1953-1958 immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:
AND WHEREAS that Committee has recommended to the Minister that the following drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953-1972, namely, the drugs and medicinal preparations specified in the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:
NOW THEREFORE I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1972.
Dated this twenty fourth day of November, 1972.
Paul Hasluck
Governor-General.
By His Excellency's Command,
Minister of State for Health.
Amendments op the National Health (Pharmaceutical Benefits) Regulations †
Commencement.
1. These Regulations shall come into operation on the first day of December, 1972.
First Schedule.
2. The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in the First Schedule to these Regulations.
Second Schedule.
3. The Second Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in the Second Schedule to these Regulations.
Third Schedule.
4. The Third Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in the Third Schedule to these Regulations.
Fifth Schedule.
5. The Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in the Fourth Schedule to these Regulations.
* Notified in the Commonwealth Gazette on 1972.
† Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; l963, Nos. 34, 69 and 107; l964, Nos. 12, 57 and 135; 1965, Nos. 51, 151 and 152; 1966, Nos. 80 and 144; l967, Nos. 67, 116 and 158; 1968, Nos. 44, 76, 88 and 146; 1969, Nos. 44, 107 and 185; 1970, Nos. 39, 94, 119 and 186; 1971, Nos. 44, 101, 136 and 154; and 1972, No. 32 and 121.
21715/72—Price 10c 9/17.11.1972
THE SCHEDULES
first SCHEDULES
Regulation 2.
Amendments of the First schedule to the National Health (pharmaceutical Benefits) Regulations.
1. After item 118 insert the following item—
“ 118a. Deoxycortone Acetate Injection ”.
2. After item 145 insert the following item—
“ 145a. Di-iodohydroxyquinoline Tablets ”.
3. After item 175 insert the following item—
“ 175a. Ethisterone Tablets ”.
 SECOND SCHEDULE
Regulation 3. Amendments of the Second Schedule to the National Health (Pharmaceutical Benefits) Regulations |
|
1. After item 6 insert the following item— |
“ 6a | Alginic Acid Compound .... | —”. |
2. Omit item 12, insert the following item— |
“ 12 | Ampicillin Trihydrate ...... | Purified Water, B.P., with Ampicillin Trihydrate ” |
3. After item 17 insert the following item— |
“ 17a | 'BANISH' ............. | —”. |
4. After item 27 insert the following item— |
“ 27a | Calcium Lactate-Gluconate | Calcium Carbonate, B.P., with Calcium Lactate-Gluconate ”. |
5. Omit from item 34 “ Hydrocortisone Acetate with Chloramphenicol ” (in the third column). |
6. After item. 42. insert the following item— |
“ 42a | Cloxacillin Sodium ....... | Purified Water, B.P., with Cloxacillin Sodium ”. |
7. After item 82 insert the following item— |
“ 82a | Folic Acid ............. | Ferrous Sulphate (Dried), B.P., with Folic Acid, B.P.”. |
8. Omit from item 93 “ Chloramphenicol with Hydrocortisone Acetate ” (in the third column). |
9. After item 96 insert the following item— |
“ 96a | 'ISOMIL' .............. | —.” |
10. After item 99 insert the following item— |
“ 99a | 'KETOVITE' Liquid ....... | —”. |
11. Omit item 117. |
12. Omit item 151, insert the following item— |
“ 151 | Phenethicillin Potassium .. | Purified Water, B.P., with Phenethicillin Potassium ”. |
13. Omit item. 166. |
14. Omit item 179. |
15. Omit item 183. |
16. After item 186 insert the following item— |
“ 186a | Sterculia .............. | —”. |
17. Omit item 188. |
18. Omit item 210. |
| | | |
SECOND SCHEDULE—continued
19. After item 213 insert the following item—
“ 213a | Triglycerides Oil, Medium Chain | —”. |
20. After item, 222 insert the following items— |
“ 222a 222b | 'ZERODOR' ............ 'ZOFF' ................ | —”. —”. |
THIRD SCHEDULE Regulation 4.
Amendments of the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations
1. After item 12 insert the following item—
“ 13. Alginic Acid Compound ”.
2. Omit item 38.
3. After item 42 insert the following item—
“ 42a. 'BANISH' ”.
4. After item 60 insert the following item—
“ 60a. Calcium Lactate-Gluconate ”.
5. After item 82 insert the following items—
“ 82a. Clindamycin Hydrochloride
“82b. Clonidine Hydrochloride ”.
6. Omit item 111.
7. After item 120 insert the following item—
“ 120a. Dipyridamole ”.
8. Omit item 121.
9. After item 164 insert the following item—
“ 164a. Hexamine Hippurate ”.
10. After item 186 insert the following item—
“ 186a. Intraperitoneal Dialysis Solutions ”.
11. After item 188 insert the following item—
“ 188a. 'ISOMIL' ”.
12. After item 191 insert the following items—
“ 191a. 'KETOVITE' Liquid
191 B. 'KETOVITE' Tablets ”.
13. Omit item 234.
14. Omit item 275.
15. Omit item 305.
16. Omit item 335.
17. After item 337 insert the following item—
“ 337a. Sodium Cromoglycate ”.
18. Omit item 341.
19. After item 350 insert the following item—
“ 350a. Sterculia ”.
20. Omit item 355.
21. After item 375 insert the following item—
“ 375a. Thiopropazate Hydrochloride ”.
22. Omit item 384.
23. After item 387 insert the following item—
“ 387a. Triglycerides Oil, Medium Chain ”.
24. After item 393 insert the following item—
“ 393a. Vancomycin Hydrochloride ”.
25. After item 401 insert the following item—
“ 401a. 'ZERODOR' ”.
26. After item 402 insert the following item—
“ 403. 'ZOFF' ”.
FOURTH SCHEDULE Regulation 5.
Amendments of the Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations
1. After item 4 insert the following item—_ | | |
“ 5 | Alginic Acid Compound ...... | Oesophageal reflux in infants ”. |
| | |
2. Omit from item 7—
“ Thyrotoxicosis" (in the third column),
insert—
“ Thyrotoxicosis
Treatment of severe hypertensive disease where other treatment has proved ineffective ”.
3. Omit from item 13—
“ (2) Ampicillin Injections, Tablets and Syrups ” (in the second column), insert—
“ (2) Ampicillin Injections and Tablets
(3) Ampicillin Trihydrate, B.P., with Purified Water, B.P. ”.
4. After item 15 insert the following item— |
“ 15a | 'BANISH' ............. | Ileostomy or colostomy conditions ”. |
5. After item 25 insert the following items—
“ 25a | Calcium Carbonate, B.P., with Calcium Lactate-Gluconate | Hypocalcaemia Hypoparathyroidism Osteoporosis |
25b | Calcium Carbonate, B.P., with Citric Acid, B.P., Compound Effervescent Powder | Hypocalcaemia Hypoparathyroidism Osteoporosis |
25c | Calcium Dioxytetracycline .. | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets |
25d | Calcium Gluconogalactogluconate Tablets | Hypocalcaemia Hypoparathyroidism Osteoporosis ”. |
6. Omit from item 10 “Cephalexin Monohydrate" (in the second column), insert—
“ (1) Cephalexin Monohydrate
(2) Cephalexin Monohydrate with Purified Water, B.P.”.
7. Omit from item 39—
“ Radiation sickness” (in the third column), insert—
“ Radiation sickness
Severe conduct disorders in patients who have not attained the age of sixteen years ”.
8. After item 40 insert the following item—
“ 40a | Clindamycin Hydrochloride .. | Gram-positive coccal infections where the infection cannot be safely and effectively treated with penicillin, or a derivative of penicillin Osteomyelitis ”. | |
9. After item 41 insert the following item— |
“ 41a | Clonidine Hydrochloride .... | Any disease or condition in a patient receiving treatment in or at an approved hospital ”. |
| | | | | |
10. Add at the end of item 42 (in the second column)—
“ (3) Cloxacillin Sodium, B.P., with Purified Water, B.P.”.
Fourth Schedule—continued
11. After item 45 insert the following item—
“ 45a | Cyclophosphamide Tablets, B.P., and Cyclophosphamide, B.P. | Any malignant disease Dermalomyositis Nephritis Nephrosis Polyarteritis nodosa Rheumatoid arthritis with vasculitis or visceral complications Scleroderma Systemic lupus erythematosus Wegener's granulomatosis ”. | |
“ 49a | Demethylchlortetracycline Hydrochloride, B.P. | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets ”. |
| | | |
12. After item 49 insert the following item—
“ 51 | (1) Deoxycortone Acetate Implants, B.P. (2) Deoxycortone Acetate, B.P. | Adrenal cortical hypofunction ”. |
13. Omit item 51, insert the following item—
14. Omit item 55.
15. After item 63 insert the following item—
“ 63a | Dipyridamole ........... | Supplementing anticoagulants in patients with cardiac prosthesis ”. |
5. After item 64 insert the following item— |
“ 64a | Doxycycline Hyclate Suspension | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets ”. |
17. Omit from item 66 “ Epicillin Capsules and Syrups ” (in the second column), insert—
“ (1) Epicillin Capsules
(2) Epicillin with Purified Water, B.P.”.
18. Omit item 70.
19. After item 71 insert the following item—
“ 71a | Ferrous Sulphate (Dried), B.P., with Folic Acid, B.P. | Prophylactic use during pregnancy ”. |
20. After item 100 insert the following item—
“ 100a | 'ISOMIL' .............. | With the written authority of the Director-General— |
| | Galactosaemia |
| | Homocystinuria |
| | Lactose intolerance |
| | Milk allergy in children who have not attained the age of four years ”. |
21. After item 103 insert the following item—
“ 103a | (1) 'KETOVITE' Liquid .... | With the written authority of the Director-General— |
| (2) 'KETOVITE' Tablets.... | Galactosaemia Persistent monosaccharide intolerance Phenylketonuria Tyrosinosis (hereditary) ”. |
Fourth Schedule—continued
22. After item 120 insert the following item—
“ 120a | Methacycline Suspension ... | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets ”. |
23. After item 125 insert the following item—
“ 125a | Methyltestosterone Tablets, B.P., 5 mg. | Hypogonadism in patients who have not attained the age of sixteen years ”. |
24. Omit from item 126—
“ (1) Methyltestosterone Tablets, B.P." (in the second column), insert—
“ (1) Methyltestosterone Tablets, B.P., 25 mg. or 50 mg.”.
25. Omit item 127, insert the following item—
“ 127 | Methysergide Maleate ..... | Carcinoid syndrome |
| | Treatment of severe recalcitrant migraine where other treatment has failed ”. |
26. Omit item 129.
27. After item 147 insert the following item—
“ 147a | Oxytetracycline Capsules, B.P., 100 mg. | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic ”. |
28. Omit item 170. insert the following item— |
“ 170 | Prindolol Tablets ......... | With the written authority of the Director-General— Dissecting aneurysm (aortic) Idiopathic hypertrophic subaortic stenosis Right ventricular out flow tract obstruction Serious arrhythmias Thyrotoxicosis The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents The treatment of severe hypertensive disease where other treatment has proved ineffective ”. |
29. Omit from item 176 all words (in the third column) after “ Thyrotoxicosis ”, insert—
“ The treatment of severe hypertensive disease where other treatment has proved ineffective ”.
30. Insert in item 180, after—
“ Homocystinuria” (in the third column) the words—
“ Primary hyperoxaluria ”.
31. Omit from item 180—
“ With the written authority of the Director-General—
Primary hyperoxaluria ” (in the third column).
32. Omit item 183.
33. Omit from item 185—
“(4) Sodium Aminosalicylate Granules ” (in the second column).
34. After item 185 insert the following item—
“ 185a | Sodium Cromoglycate ..... | With the written authority of the Director-General, the treatment of chronic intractable asthma ”. |
35. After item 191 insert the following item— |
“ 191a | Sterculia .............. | Ileostomy or colostomy conditions ”. |
Fourth Schedule—continued
36. After item 197 insert the following items—
“ 197A | Tetracosactrin ........... | With the written authority of the Director-General— Hypsarrhythmia Treatment of patients who are being withdrawn from long-term corticosteriod therapy |
197b | Tetracycline Capsules, B.P., 100 mg. | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
197c | Tetracycline Hydrochloride, B.P., Syrup | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets |
197d | Tetracycline Hydrochloride with Nystatin, Capsules, 100 mg., 125,000 units | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
197e | Tetracycline Hydrochloride with Nystatin, Syrups | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets |
197f | Tetracycline with a buffering agent, Capsules, 100 mg. | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
197g | Tetracycline with a buffering agent, Syrups | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets |
197h | Tetracycline with both a buffering agent and Amphotericin B | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic Treatment of patients who have attained the age of eight years and who are unable to swallow either capsules or tablets |
197i | Tetracycline with both a buffering agent and Nystatin, B.P., Capsules, 100 mg., 125,000 units | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic ”. |
37. After item 199 insert the following item—
“ 199a | Thiopropazate Hydrochloride | With the written authority of the Director-General hereditary chorea (Huntington's) ”. |
38. Omit item 202.
39. After item 204 insert the following item—
“ 204a | Triglycerides Oil, Medium Chain | With the written authority of the Director-General proven malabsorption ”. |
40. After item 206 insert the following item— |
“ 206A | Vancomycin Hydrochloride | Any disease or condition in a patient receiving treatment in or at an approved hospital ”. |
40. After item 210 insert the following item— |
“ 211 | 'ZERODOR' ............ | Ileostomy or colostomy conditions |
212 | 'ZOFF' ............... | Ileostomy or colostomy conditions ”. |
Printed by Authority by the Government Printer of the Commonwealth of Australia